Edition:
United Kingdom

Biotechnology & Medical Research

Immune Therapeutics Says Kenya Pharmacy & Poison Board Filed Co's NDA For Lodona, Thereby Accepting NDA For Full Review

April 26 (Reuters) - Immune Therapeutics Inc ::IMMUNE THERAPEUTICS SAYS KENYA PHARMACY & POISON BOARD FILED CO'S NDA FOR LODONA THEREBY, ACCEPTING NDA FOR FULL REVIEW.

1:30pm BST

Axsome Therapeutics Says Independent Committee Recommends Continuation Of Depression Trial

April 26 (Reuters) - Axsome Therapeutics Inc ::AXSOME THERAPEUTICS ANNOUNCES POSITIVE OUTCOME OF INTERIM ANALYSIS OF STRIDE-1 PHASE 3 TRIAL OF AXS-05 IN TREATMENT RESISTANT DEPRESSION.AXSOME THERAPEUTICS INC - SECOND INTERIM ANALYSIS ANTICIPATED SECOND HALF OF 2018 FOR EFFICACY.AXSOME THERAPEUTICS...

12:00pm BST

Merus Q4 Loss Per Share EUR 0.73

April 26 (Reuters) - Merus NV ::MERUS ANNOUNCES RECENT CORPORATE DEVELOPMENTS AND FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017.Q4 LOSS PER SHARE EUR 0.73.Q4 EARNINGS PER SHARE VIEW EUR -0.62 -- THOMSON REUTERS I/B/E/S.QTRLY TOTAL REVENUE WAS EUR 3.8 MILLION VERSUS NEGATIVE EUR 0.4...

12:00pm BST

Microbix Biosystems - Engaged Torreya Partners To Assist It With Reaching An Agreement That Enables Re-Launch Of Kinlytic Into U.S.Market

April 26 (Reuters) - Microbix Biosystems Inc ::MICROBIX BIOSYSTEMS - ENGAGED TORREYA PARTNERS TO ASSIST IT WITH REACHING AN AGREEMENT THAT ENABLES RE-LAUNCH OF KINLYTIC INTO UNITED STATES MARKET.

12:00pm BST

Expansion & New Markets

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.